# K220498: NovoGen Wound Matrix

- Pathway: 510(k) (Traditional)
- Applicant: Novabone Products, LLC
- Decided: Jun 9, 2023 after 472 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K960978 (1996). 61 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 63 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K092096: Endoform Dermal Template, Mesynthes, Ltd. (2010) Summary page 4.
- K110368: Novabone Putty - Bioactive Synthetic Bone Graft, Novabone Products, LLC (2011) Summary page 4.

## Most influential descendants
- K260711: Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP) (2026), 0 descendants of its own

## Indications for use
NovoGen Wound Matrix is indicated for the management of wounds including: • Partial and full-thickness wounds • Pressure ulcers • Venous ulcers • Diabetic ulcers • Chronic vascular ulcers • Tunneled/undermined wounds • Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) • Trauma wounds (abrasions, lacerations, partial thickness burns, and skin tears) • Draining wounds

Source page: https://510kreport.com/device/K220498
Methodology: https://510kreport.com/methodology